General
| Peptide: | Lys-a1 |
| Microorganism: | Streptococcus parasanguinis ATCC 903 |
| Administration: | |
| Stage: | Formation (3-24h) |
| Notes: |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| Crystal violet assay | 51 - 90% | 0.92 uM | |
| Crystal violet assay | > 90% | 1.888 uM | |
| Total countable CFUs | >= 3 log | 0.92 uM |
Reference
- Bruno Rocha da Silva, Victor Aragão Abreu de Freitas, Victor Alves Carneiro, Francisco Vassiliepe Sousa Arruda, Esteban Nicolás Lorenzón, Andréa Silvia Walter de Aguiar, Eduardo Maffud Cilli, Benildo Sousa Cavada, Edson Holanda Teixeira Antimicrobial activity of the synthetic peptide Lys-a1 against oral streptococci
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com